SCHEMBL3234467

SCHEMBL3234467

CCOc1ccc2c(c1)C(C)(c1cc(C(=O)NC(C)O)ccc1Cl)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.42
USP2 O75604 2/20 0.36
MAPT P10636 3/20 0.36
GNRHR P30968 1/20 0.36
RECQL P46063 1/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
BCL2L1 Q07817 1/20 0.34
MCL1 Q07820 1/20 0.34
PTGDR Q13258 1/20 0.34
POLB P06746 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3228428 0.90 AVPR1A (0.43) AVPR1AUSP2MAPTGNRHRRECQL
SCHEMBL3222818 0.90 AVPR1A (0.44) AVPR1AUSP2MAPTGNRHRRECQL
SCHEMBL3230272 0.88 AVPR1A (0.42) AVPR1AMAPTGNRHRRECQLLMNA
SCHEMBL3237022 0.88 AVPR1A (0.39) AVPR1AUSP2MAPTGNRHRRECQL
SCHEMBL3233778 0.88 AVPR1A (0.41) AVPR1AMAPTGNRHRRECQLLMNA
SCHEMBL3233628 0.87 AVPR1A (0.43) AVPR1AUSP2MAPTGNRHRRECQL
SCHEMBL3233812 0.86 AVPR1A (0.46) AVPR1AMAPTLMNAMEN1KMT2A
SCHEMBL3225093 0.86 MAPT (0.42) AVPR1AMAPTGNRHRLMNAMEN1
SCHEMBL3238705 0.85 AVPR1A (0.44) AVPR1AMAPTGNRHRRECQLLMNA
SCHEMBL3238699 0.85 AVPR1A (0.44) AVPR1AMAPTGNRHRRECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY SANOFI-AVENTIS (FR) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069384-A1 5-ALKYLOXY-INDOLIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPY AVPR2, AVPR1A, AVPR1B AVPR1A 2/4885USP2 4261/4885MAPT 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.